Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:00 pm Sale | 2023-12-31 | 13G | INFLARX N V COM IFRX | TANG CAPITAL PARTNERS LP | 1,873,753 3.200% | -1,126,247 (-37.54%) | Filing History |
| 2024-02-14 4:00 pm Sale | 2023-12-31 | 13G | KINNATE BIOPHARMA INC KNTE | TANG CAPITAL PARTNERS LP | 2,601,647 5.500% | -364,068 (-12.28%) | Filing History |
| 2024-02-14 4:00 pm Sale | 2023-12-31 | 13G | TCR2 THERAPEUTICS INC TCRR | TANG CAPITAL PARTNERS LP | 0 0.000% | -4,215,864 (Position Closed) | Filing History |
| 2024-02-14 4:00 pm Sale | 2023-12-31 | 13G | TONIX PHARMACEUTICALS HLDG COM TNXP | TANG CAPITAL PARTNERS LP | 0 0.000% | -225 (Position Closed) | Filing History |
| 2024-02-14 4:00 pm Sale | 2023-12-31 | 13G | BELLEROPHON THERAPEUTICS INC C BLPH | TANG CAPITAL PARTNERS LP | 0 0.000% | -1,062,619 (Position Closed) | Filing History |
| 2024-02-14 4:00 pm Sale | 2023-12-31 | 13G | BIOATLA INC BCAB | TANG CAPITAL PARTNERS LP | 2,524,076 5.300% | -600,000 (-19.21%) | Filing History |
| 2024-02-14 4:00 pm Sale | 2023-12-31 | 13G | BIONOMICS LTD ADS BNOX | TANG CAPITAL PARTNERS LP | 0 0.000% | -10,500,000 (Position Closed) | Filing History |
| 2024-02-14 4:00 pm Purchase | 2023-12-31 | 13G | BOLT BIOTHERAPEUTICS, INC BOLT | TANG CAPITAL PARTNERS LP | 182,612 9.600% | 45,999 (+33.67%) | Filing History |
| 2024-02-14 4:00 pm Purchase | 2023-12-31 | 13G | CYTOMX THERAPEUTICS INC CTMX | TANG CAPITAL PARTNERS LP | 6,550,000 9.800% | 3,039,555 (+86.59%) | Filing History |
| 2024-02-14 4:00 pm Purchase | 2023-12-31 | 13G | ELEVATION ONCOLOGY INC ELEV | TANG CAPITAL PARTNERS LP | 4,300,454 9.990% | 2,944,628 (+217.18%) | Filing History |
| 2024-02-14 4:00 pm Sale | 2023-12-31 | 13G | GENFIT S A ADS GNFTY | TANG CAPITAL PARTNERS LP | 479,441 1.000% | -2,163,706 (-81.86%) | Filing History |
| 2024-02-14 4:00 pm Purchase | 2023-12-31 | 13G | KALVISTA PHARMACEUTICALS INC C KALV | TANG CAPITAL PARTNERS LP | 3,440,345 9.960% | 243,899 (+7.63%) | Filing History |
| 2024-02-14 4:00 pm Sale | 2023-12-31 | 13G | LITE STRATEGY INC PAR $ LITS | TANG CAPITAL PARTNERS LP | 326,084 4.900% | -35,000 (-9.69%) | Filing History |
| 2024-02-14 4:00 pm Sale | 2023-12-31 | 13G | PYXIS ONCOLOGY INC PYXS | TANG CAPITAL PARTNERS LP | 0 0.000% | -3,470,700 (Position Closed) | Filing History |
| 2024-02-14 4:00 pm Purchase | 2023-12-31 | 13G | REVIVA PHARMACEUTICALS HLDGS C RVPH | TANG CAPITAL PARTNERS LP | 154,931 9.990% | 41,620 (+36.73%) | Filing History |
| 2024-02-14 4:00 pm Purchase | 2023-12-31 | 13G | TARSUS PHARMACEUTICALS INC TARS | TANG CAPITAL PARTNERS LP | 2,204,797 6.700% | 203,212 (+10.15%) | Filing History |
| 2024-02-14 4:00 pm Sale | 2023-12-31 | 13G | THARIMMUNIE INC THAR | TANG CAPITAL PARTNERS LP | 0 0.000% | -16,837 (Position Closed) | Filing History |
| 2024-02-05 4:49 pm Purchase | 2024-01-24 | 13G | PRECISION BIOSCIENCES INC DTIL | TANG CAPITAL PARTNERS LP | 213,333 5.200% | 213,333 (New Position) | Filing History |
| 2024-02-05 4:48 pm Purchase | 2024-01-24 | 13G | GRAPHITE BIO INC GRPH | TANG CAPITAL PARTNERS LP | 445,406 5.400% | 445,406 (New Position) | Filing History |
| 2024-02-02 4:00 pm Sale | 2024-01-26 | 13D | RAIN ONCOLOGY INC. RAIN | TANG CAPITAL PARTNERS LP | 0 0.000% | -4,024,486 (Position Closed) | Filing History |